36C24524Q0322_1.docx

36C24524Q0322

GENERAL INFORMATION

SET-ASIDE

VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101, Room 26 Perry Point MD 21902

POINT OF CONTACT*

Contracting Officer Kami Hom Kami.Hom@va.gov

PLACE OF PERFORMANCE

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

DESCRIPTION

See RFQ below.

All Questions are due in writing to Kami.Hom@va.gov by March 18, 2024 no later than 1:00pm est.

All Responses are due in writing to Kami.Hom@va.gov by March 21, 2024 no later than 10:00am est.

Fill out and return Line items template with response.

Combined Synopsis/Solicitation Notice Combined Synopsis/Solicitation Notice

Combined Synopsis/Solicitation Notice

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a. PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

UEI:

EFT:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA

26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

36C24524Q0322 Kami Hom 410-642-2411 x22404 03- -2024 :00 a m

EDT

Department of Veterans Affairs VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101, Room 26 Perry Point MD 21902 X 325412 $4 Million N/A X Department of Veterans Affairs VA Maryland Health Care System 10 North Greene Street Baltimore MD 21201 Department of Veterans Affairs VA Maryland Health Care System Contracting Officer (90C) P.O. Box 1000, Bldg. 101C Room 3 Perry Point MD 21902

PAYMENT WILL BE MADE BY

FSC e-Invoice Payment Invoice must be submitted electronically http://www.fsc.va.gov/einvoice.asp Invoice Setup Information 1-877-489-6135 See CONTINUATION Page Radio-Pharmaceutical Isotopes for Nuclear Medicine Period of Performance 04/01/2024 - 03/31/2029 Please see pages 4-4 for detailed information.

All Questions are due in writing to Kami.Hom@va.gov by March 1 , 2024 no later than

:00 p m est.

All Responses are due in writing to Kami.Hom@va.gov by March , 2024 no later than 10:00am est.

See CONTINUATION Page X X Kami Hom Contracting Officer Page 1 of Table of Contents

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

b. GOVERNMENT: Department of Veterans Affairs VA Maryland Health Care System Kami Hom, Contracting Officer (90C) P.O. Box 1000, Bldg. 101-C, Room 8 Perry Point MD 21902 410-642-2411 x22404 Kami.Hom@va.gov

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

3. INVOICES: Invoices shall be submitted in arrears:

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

http://www.fsc.va.gov/einvoice.asp

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

B.2 STATEMENT OF WORK

Statement of Work Blanket Purchase Agreement (BPA) for Medical Isotope Supply for Baltimore VA Medical Center

1. Overview This Blanket Purchase Agreement (BPA) establishes a relationship between the Baltimore VA Medical Center located at 10 North Greene Street, Baltimore, MD 21201 (hereinafter referred to as "BT VAMC") and the contractor, for the supply of Radiopharmaceutical products and delivery services. The contractor shall provide all items as listed in the Supplies and Service Schedule of this contract. It is the intent of the Government to make a single award for this Radio-pharmaceuticals be furnished on a daily, as needed basis, as determined by the Nuclear Medicine and PET departments. Miland Valencia acts as the authorized representative for the BT VAMC in this BPA.

2. Regulatory Compliance The Contractor shall ensure full compliance with all applicable federal, state, and local laws, regulations, and guidelines pertaining to the manufacturing, handling, storage, transportation, and disposal of radiopharmaceuticals, including but not limited to the following:

A. Nuclear Regulatory Commission (NRC): Adherence to all NRC regulations concerning the use, storage, handling, and disposal of radioactive materials. This includes maintaining valid licenses for the possession and distribution of radiopharmaceuticals and ensuring that all personnel involved in the handling of these materials are properly trained and licensed.

B. Food and Drug Administration (FDA): Compliance with FDA regulations for the approval, production, labeling, and distribution of radiopharmaceuticals. This includes adherence to Current Good Manufacturing Practices (cGMPs) as outlined in 21 CFR Parts 210 and 211, and meeting requirements for drug efficacy and safety reporting.

C. Department of Transportation (DOT): Compliance with DOT regulations for the safe and secure transportation of hazardous materials, as outlined in 49 CFR Parts 100-185. The Contractor must ensure that all shipments of radiopharmaceuticals are properly classified, packaged, marked, labeled, and accompanied by the appropriate shipping documentation.

D. The Contractor must maintain all records of compliance and make them available for review upon request by the Baltimore VA Medical Center or any regulatory body. In the event of any changes in applicable laws or regulations, the Contractor is required to promptly adjust its operations to maintain compliance and notify the Baltimore VA Medical Center of any such changes that may affect the provision of services under this agreement.

The Contractor's failure to comply with any of the above regulatory requirements may result in immediate termination of this contract, at the discretion of the Baltimore VA Medical Center, in addition to any other remedies available under law.

3. Product Supply and Availability The Contractor is responsible for the consistent, reliable supply of high-quality radiopharmaceuticals to the Baltimore VA Medical Center. This responsibility encompasses the following detailed provisions:

A. Product Range: The Contractor shall provide a comprehensive list of radiopharmaceuticals available under this BPA, including but not limited to, those required for diagnostic imaging, therapy, and research purposes. This list should be updated periodically to reflect any new products or changes in availability.

B. Supply Reliability: The Contractor guarantees a reliability rate of 98% for the timely delivery of ordered radiopharmaceuticals. This rate is calculated as the percentage of on-time deliveries out of the total deliveries within a specified period.

C. Order Fulfillment: The Contractor commits to fulfilling orders placed by the Baltimore VA Medical Center within the agreed-upon delivery windows. For products in high demand or with short half-lives, the Contractor shall prioritize order processing and utilize expedited shipping methods when necessary to meet delivery timelines.

D. Quality Assurance: All supplied radiopharmaceuticals must meet or exceed the quality standards specified by the Food and Drug Administration (FDA) and relevant industry standards. The Contractor is responsible for ensuring that each product batch is accompanied by a Certificate of Analysis (CoA) verifying its identity, strength, purity, and quality.

E. Emergency Supply: In the event of urgent or unexpected needs, the Contractor shall have a procedure in place for emergency orders. This includes the ability to expedite processing and delivery of radiopharmaceuticals to address critical shortages or immediate patient care needs.

F. Backorder Management: Should any product become temporarily unavailable (backordered), the Contractor must immediately notify the Baltimore VA Medical Center, providing an estimated availability date and suggesting equivalent alternative products if available. The Contractor shall take all reasonable steps to resolve backorders and resume supply as quickly as possible.

G. Reporting and Communication: Regular communication channels shall be maintained to ensure the Baltimore VA Medical Center is informed of any developments affecting product supply and availability.

Failure to adhere to these supply and availability requirements may result in penalties, including but not limited to financial compensation for the Baltimore VA Medical Center, and may impact the Contractor's eligibility for contract renewal.

4. Labeling and Packaging The Contractor is required to adhere to strict labeling and packaging standards for all radiopharmaceuticals supplied under this BPA, ensuring compliance with federal, state, and local regulations, and promoting the safe handling and use of these materials. The requirements include:

A. Labeling: Each product must be labeled clearly and legibly with all necessary information, including but not limited to:

- The name of the radiopharmaceutical.

- The radionuclide and its activity in Becquerels or Curies, including the calibration time.

- Expiry date/time.

- Lot or batch number.

- Manufacturer's name and address.

- Appropriate radiation symbols and warnings.

- Any specific handling instructions.

The label must also include a barcode or QR code that links to a digital copy of the detailed product information and handling instruction.

B. Packaging: Packaging must ensure the integrity and safety of the radiopharmaceuticals during transportation and storage. This includes:

I. Use of lead or equivalent shielding containers for radioactive materials to ensure exposure levels are as low as reasonably achievable (ALARA).

II. Secondary containment to prevent leakage or contamination in the event of primary container failure.

III. Packaging materials that are compatible with the radiopharmaceuticals to avoid chemical degradation or reactions.

IV. Tamper-evident features to indicate if the product has been opened or altered after leaving the manufacturing facility.

C. Transportation Packaging: In addition to the above, packaging for transportation must comply with Department of Transportation (DOT) regulations for hazardous materials. This includes:

I. Proper classification, marking, and labeling of packages as per DOT requirements.

II. Use of UN-approved shipping containers for radioactive materials.

III. Inclusion of all necessary shipping papers, emergency response information, and declarations for dangerous goods.

D. Documentation: Each shipment must be accompanied by documentation that includes the product's name, quantity, lot number, expiration date, and a Certificate of Analysis (CoA). Safety data sheets (SDS) for each radiopharmaceutical must also be provided, detailing hazards, handling precautions, and first-aid measures upon request.

E. Custom Labeling and Packaging: Upon request, the Contractor must be able to provide custom labeling and packaging solutions to meet specific needs of the Baltimore VA Medical Center, such as unit-dose packaging or patient-specific labeling.

Failure to comply with these labeling and packaging requirements may result in the rejection of delivered products, financial penalties, and/or termination of the contract. The Contractor is responsible for any costs associated with the return, replacement, or disposal of non-compliant products.

6. Returns and Credits The contractor shall accept returns for credit under specific conditions, such as errors in order or shipment, damaged products, recalled products, and outdated products in unopened, original containers. A clear return policy and process for invoice adjustments will be communicated to the BT VAMC.

7. Invoicing The Contractor shall submit certified invoices on a monthly basis, detailing all transactions within the billing period, including product names, quantities, amounts, and any credits for returns.

8. Ordering Process Post-award, the contractor will be provided with the names of individuals authorized by the Baltimore VA Medical Center to place orders against this BPA. The Contracting Officer Representative (COR), designated by the medical center, will oversee the administration and compliance with the BPA terms.

9. Specifications and Schedule Specifications for the radiopharmaceutical products and the delivery schedule will be based on the as-needed requests by the Nuclear Medicine and PET departments of the Baltimore VA Medical Center. The contractor is required to provide service through normal business hours and on call after hours 24/7 coverage if requested and comply with delivery and quality control specifications as detailed. Unit dose containers shall be picked up daily. Contractor to supply and deliver twice a day on normal working days, with the first delivery by 7:00 am eastern standard time. Emergency deliveries shall be received withing one (2) hour of request. Daily “call-in” or “on-line” orders by authorized person(s) or doses required by following morning. Confirmation of orders is reviewed and received.

--any other day specifically declared by the President of the United States to be a national holiday.

10. Duration This BPA is effective from date of award for five (5) years, subject to the terms and conditions herein.

11. Provision for Product List Updates and New Product Additions The Contractor acknowledges the importance of providing the most current and effective radiopharmaceuticals to meet the evolving needs of the Baltimore VA Medical Center. Therefore, it is agreed as follows:

A. Updated Product List: The Contractor shall maintain an up-to-date list of all radiopharmaceuticals available under this Blanket Purchase Agreement (BPA). This list will include detailed information on each product, including specifications, intended use, and regulatory compliance status. The Contractor commits to providing the Baltimore VA Medical Center with updates to this product list at a minimum on a quarterly basis, or more frequently as new products become available or existing products are discontinued. Below is the current product list anticipated for order.

Product Description

F-18 FDG UD

F-18 FDG UD Source

F-18 NaF UD

Ga-67 Gallium Citrate UD (per mCi)

I-131 USP NaI DX Cap mCi

I-131 USP NaI DX Cap uCi (per cap)

I-131 USP NaI TX Cap (up to 6 mCi)

I-131 USP NaI TX Cap (each addl mCi)

In-111 Pentetreotide UD

In-111 WBC Bld Kit (Heparin&Hetastarch)

In-111 WBC Blood Kit (Heparin)

In-111 Autologous WBC Suspension

Pyrophosphate Vial

Sincalide Vial

Syntrac Integration Tools License Fee

Tc-99m Bicisate UD

Tc-99m Filtered Sulfur Colloid UD

Tc-99m Macro Aggregated Albumin UD

Tc-99m Mebrofenin UD

Tc-99m Medronate UD

Tc-99m Mertiatide UD

Tc-99m NaTcO4 MD (per mCi)

Tc-99m NaTcO4 UD mCi (up to 30 mCi)

Tc-99m Pyrophosphate UD

Tc-99m Sestamibi UD (up to 30 mCi)

Tc-99m Sulfur Colloid UD

Tc-99m Tetrofosmin UD (up to 30 mCi)

Tc-99m WBC Blood Kit (Heparin)

Tc-99m Exametazime WBC's

Tl-201 Thallous Chloride UD (per mCi)

UltraTag Vial

Xe-133 Xenon Gas 20 mCi Vial

Cu-64 Dotatate

B. New Product Additions: Throughout the duration of this contract, the Contractor may introduce new radiopharmaceuticals to the market. Any new product that is added to the Contractor's offering during the term of this contract will automatically be deemed included within the scope of this BPA and available for purchase by the Baltimore VA Medical Center. The Contractor shall promptly notify the Baltimore VA Medical Center of such additions, providing full product details and any special handling or usage instructions.

C. Order Eligibility: The Baltimore VA Medical Center shall have the right to order any products listed on the updated product list, including any new products added during the duration of the contract, under the terms and conditions established herein.

This ensures that the Baltimore VA Medical Center has access to the latest advancements in radiopharmaceuticals and can adapt its treatment options to incorporate these innovations, thereby enhancing patient care.

By agreeing to these provisions, both parties affirm their commitment to a dynamic and responsive partnership that prioritizes patient care and embraces the ongoing advancements in radiopharmaceutical technology.

12. Points of Contact

- CO (Contracting Officer): Kami Hom

- COR (Contracting Officer's Representative): Miland Valencia

- Contractor Designee: [Contractor representative's name]

B.3 PRICE/COST SCHEDULE

ITEM INFORMATION

Daily formulation and delivery of Neulear Isotopes products for patient care in Nuclear Medicine and PET/CT for the period of 4/1/2024 - 03/31/2025 Contract Period: Base POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

0001AA

F-18 FDG UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102192

NATIONAL STOCK NUMBER: 102192

LOCAL STOCK NUMBER: 102192

0001AB

F-18 FDG UD Source

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102193

NATIONAL STOCK NUMBER: 102193

LOCAL STOCK NUMBER: 102193

0001AC

F-18 NaF UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102204

NATIONAL STOCK NUMBER: 102204

LOCAL STOCK NUMBER: 102204

0001AD

Ga-67 Gallium Citrate UD (per mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102279

NATIONAL STOCK NUMBER: 102279

LOCAL STOCK NUMBER: 102279

0001AE

I-131 USP NaI DX Cap mCi

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102366

NATIONAL STOCK NUMBER: 102366

LOCAL STOCK NUMBER: 102366

0001AF

I-131 USP NaI DX Cap uCi (per cap)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102367

NATIONAL STOCK NUMBER: 102367

LOCAL STOCK NUMBER: 102367

0001AG

I-131 USP NaI TX Cap (up to 6 mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

NATIONAL STOCK NUMBER: 102372

LOCAL STOCK NUMBER: 102372

0001AH

I-131 USP NaI TX Cap (each addl mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0001AI

In-111 Pentetreotide UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102400

NATIONAL STOCK NUMBER: 102400

LOCAL STOCK NUMBER: 102400

0001AJ

In-111 WBC Bld Kit (Heparin&Hetastarch)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102408

NATIONAL STOCK NUMBER: 102408

LOCAL STOCK NUMBER: 102408

0001AK

In-111 WBC Blood Kit (Heparin)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102409

NATIONAL STOCK NUMBER: 102409

LOCAL STOCK NUMBER: 102409

0001AL

In-111 Autologous WBC Suspension

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102410

NATIONAL STOCK NUMBER: 102410

LOCAL STOCK NUMBER: 102410

0001AM

Pyrophosphate Vial

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102684

NATIONAL STOCK NUMBER: 102684

LOCAL STOCK NUMBER: 102684

0001AN

Sincalide Vial

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102767

NATIONAL STOCK NUMBER: 102767

LOCAL STOCK NUMBER: 102767

0001AO

Syntrac Integration Tools License Fee

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102810

NATIONAL STOCK NUMBER: 102810

LOCAL STOCK NUMBER: 102810

0001AP

Tc-99m Bicisate UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102932

NATIONAL STOCK NUMBER: 102932

LOCAL STOCK NUMBER: 102932

0001AQ

Tc-99m Filtered Sulfur Colloid UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102943

NATIONAL STOCK NUMBER: 102943

LOCAL STOCK NUMBER: 102943

0001AR

Tc-99m Macro Aggregated Albumin UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102970

NATIONAL STOCK NUMBER: 102970

LOCAL STOCK NUMBER: 102970

0001AS

Tc-99m Mebrofenin UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102974

NATIONAL STOCK NUMBER: 102974

LOCAL STOCK NUMBER: 102974

0001AT

Tc-99m Medronate UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102977

NATIONAL STOCK NUMBER: 102977

LOCAL STOCK NUMBER: 102977

0001AU

Tc-99m Mertiatide UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102980

NATIONAL STOCK NUMBER: 102980

LOCAL STOCK NUMBER: 102980

0001AV

Tc-99m NaTcO4 MD (per mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102983

NATIONAL STOCK NUMBER: 102983

LOCAL STOCK NUMBER: 102983

0001AW

Tc-99m NaTcO4 UD mCi (up to 30 mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102984

NATIONAL STOCK NUMBER: 102984

LOCAL STOCK NUMBER: 102984

0001AX

Tc-99m Pyrophosphate UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102991

NATIONAL STOCK NUMBER: 102991

LOCAL STOCK NUMBER: 102991

0001AY

Tc-99m Sestamibi UD (up to 30 mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102994

NATIONAL STOCK NUMBER: 102994

LOCAL STOCK NUMBER: 102994

0001AZ

Tc-99m Sulfur Colloid UD

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103003

NATIONAL STOCK NUMBER: 103003

LOCAL STOCK NUMBER: 103003

0001BA

Tc-99m Tetrofosmin UD (up to 30 mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103006

NATIONAL STOCK NUMBER: 103006

LOCAL STOCK NUMBER: 103006

0001BB

Tc-99m WBC Blood Kit (Heparin)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103011

NATIONAL STOCK NUMBER: 103011

LOCAL STOCK NUMBER: 103011

0001BC

Tc-99m Exametazime WBC's

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103012

NATIONAL STOCK NUMBER: 103012

LOCAL STOCK NUMBER: 103012

0001BD

Tl-201 Thallous Chloride UD (per mCi)

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103039

NATIONAL STOCK NUMBER: 103039

LOCAL STOCK NUMBER: 103039

0001BE

UltraTag Vial

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103080

NATIONAL STOCK NUMBER: 103080

LOCAL STOCK NUMBER: 103080

0001BF

Xe-133 Xenon Gas 20 mCi Vial

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103099

NATIONAL STOCK NUMBER: 103099

LOCAL STOCK NUMBER: 103099

0001BG

Cu-64 Dotatate

POP Begin: 04-01-2024 POP End: 03-31-2025 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 107858

NATIONAL STOCK NUMBER: 107858

LOCAL STOCK NUMBER: 107858

Daily formulation and delivery of Neulear Isotopes products for patient care in Nuclear Medicine and PET/CT for the period of 4/1/2024 - 03/31/2025

POP Begin: 04-01-2025 POP End: 03-31-2026

0002AA

F-18 FDG UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102192

0002AB

F-18 FDG UD Source

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102193

0002AC

F-18 NaF UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102204

0002AD

Ga-67 Gallium Citrate UD (per mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102279

0002AE

I-131 USP NaI DX Cap mCi

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102366

0002AF

I-131 USP NaI DX Cap uCi (per cap)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102367

0002AG

I-131 USP NaI TX Cap (up to 6 mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0002AH

I-131 USP NaI TX Cap (each addl mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0002AI

In-111 Pentetreotide UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102400

0002AJ

In-111 WBC Bld Kit (Heparin&Hetastarch)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102408

0002AK

In-111 WBC Blood Kit (Heparin)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102409

0002AL

In-111 Autologous WBC Suspension

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102410

0002AM

Pyrophosphate Vial

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102684

0002AN

Sincalide Vial

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102767

0002AO

Syntrac Integration Tools License Fee

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102810

0002AP

Tc-99m Bicisate UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102932

0002AQ

Tc-99m Filtered Sulfur Colloid UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102943

0002AR

Tc-99m Macro Aggregated Albumin UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102970

0002AS

Tc-99m Mebrofenin UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102974

0002AT

Tc-99m Medronate UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102977

0002AU

Tc-99m Mertiatide UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102980

0002AV

Tc-99m NaTcO4 MD (per mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102983

0002AW

Tc-99m NaTcO4 UD mCi (up to 30 mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102984

0002AX

Tc-99m Pyrophosphate UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102991

0002AY

Tc-99m Sestamibi UD (up to 30 mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102994

0002AZ

Tc-99m Sulfur Colloid UD

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103003

0002BA

Tc-99m Tetrofosmin UD (up to 30 mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103006

0002BB

Tc-99m WBC Blood Kit (Heparin)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103011

0002BC

Tc-99m Exametazime WBC's

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103012

0002BD

Tl-201 Thallous Chloride UD (per mCi)

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103039

0002BE

UltraTag Vial

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103080

0002BF

Xe-133 Xenon Gas 20 mCi Vial

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103099

0002BG

Cu-64 Dotatate

POP Begin: 04-01-2025 POP End: 03-31-2026 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 107858

Daily formulation and delivery of Neulear Isotopes products for patient care in Nuclear Medicine and PET/CT for the period of 4/1/2024 - 03/31/2025

POP Begin: 04-01-2026 POP End: 03-31-2027

0003AA

F-18 FDG UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102192

0003AB

F-18 FDG UD Source

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102193

0003AC

F-18 NaF UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102204

0003AD

Ga-67 Gallium Citrate UD (per mCi)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102279

0003AE

I-131 USP NaI DX Cap mCi

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102366

0003AF

I-131 USP NaI DX Cap uCi (per cap)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102367

0003AG

I-131 USP NaI TX Cap (up to 6 mCi)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0003AH

I-131 USP NaI TX Cap (each addl mCi)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102372

0003AI

In-111 Pentetreotide UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102400

0003AJ

In-111 WBC Bld Kit (Heparin&Hetastarch)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102408

0003AK

In-111 WBC Blood Kit (Heparin)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102409

0003AL

In-111 Autologous WBC Suspension

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102410

0003AM

Pyrophosphate Vial

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102684

0003AN

Sincalide Vial

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102767

0003AO

Syntrac Integration Tools License Fee

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102810

0003AP

Tc-99m Bicisate UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102932

0003AQ

Tc-99m Filtered Sulfur Colloid UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102943

0003AR

Tc-99m Macro Aggregated Albumin UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102970

0003AS

Tc-99m Mebrofenin UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102974

0003AT

Tc-99m Medronate UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102977

0003AU

Tc-99m Mertiatide UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102980

0003AV

Tc-99m NaTcO4 MD (per mCi)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102983

0003AW

Tc-99m NaTcO4 UD mCi (up to 30 mCi)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102984

0003AX

Tc-99m Pyrophosphate UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102991

0003AY

Tc-99m Sestamibi UD (up to 30 mCi)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 102994

0003AZ

Tc-99m Sulfur Colloid UD

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103003

0003BA

Tc-99m Tetrofosmin UD (up to 30 mCi)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS CODE: 325412 - Pharmaceutical Preparation Manufacturing PRODUCT/SERVICE CODE: 6505 - Drugs and Biologicals

MANUFACTURER PART NUMBER (MPN): 103006

0003BB

Tc-99m WBC Blood Kit (Heparin)

POP Begin: 04-01-2026 POP End: 03-31-2027 PRINCIPAL NAICS…